Ticker Symbol: XENE
Xenon Pharmaceuticals Inc
$31.99 - 17-09-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Canada
Currency:
USD
Asset
Type: Common Stock
CIK:0001582313
Company Profile
Xenon is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. The Company is advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 3650 Gilmore Way
Website: www.xenon-pharma.com
CEO: Simon Pimstone
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $33.58
Change:
$0.52
(
1.57%)
Days Range: $32.65 - $33.77
Beta: 0.57
52wk. High: $43.75
52wk. Low: $31.79
Ytd. Change -14.58%
50 Day Moving Average: $35.79
200 Day Moving Average: $38.19
Shares Outstanding: 64145523
Valuation
Market Cap: 215.4B
PE Ratio: -
EPS (TTM): -2.5
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A